Thomas John Dietz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas John Dietz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas John Dietz. Thomas John Dietz is a Director in Paratek Pharmaceuticals, Inc. ($PRTK) and a Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and a Director in LEAP THERAPEUTICS, INC. ($LPTX).
Address: C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD STE 110 PT. RICHMOND 94804 CA
Companies in which Thomas John Dietz is an Insider
Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas John Dietz: Director
Holdings: 36,500 shares
Current Value: $423,400
Latest Transaction: Apr 12 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LEAP THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas John Dietz: Director
Holdings: 0 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas John Dietz: Director
Holdings: 30,000 shares
Current Value: $457,500
Latest Transaction: Feb 22 2021
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas John Dietz
Sentiment: All, EIGR, LPTX, PRTK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.50 | 1,000 | 8,500 | 37,500 | 36.5 K to 37.5 K (+2.74 %) |
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.48 | 1,500 | 12,720 | 36,500 | 35 K to 36.5 K (+4.29 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.99 | 20,000 | 199,800 | 20,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Dietz Thomas John | Director | Grant | A | 0.00 | 9,000 | 0 | 30,000 | 21 K to 30 K (+42.86 %) |
| Jan 06 2021 | LPTX | LEAP THERAPEUTICS, ... | Dietz Thomas John | Director | Option Exercise | A | 2.18 | 37,300 | 81,314 | 37,300 |